|Recommended monitoring during EXJADE treatment|
|Baseline||In the first month after
initiation of EXJADE
|Creatinine clearance and/or plasma cystatin C||2X||Weekly1|
bilirubin, alkaline phosphatase
|Every 2 Weeks|
|Body weight, height,
and sexual development
|Other markers of renal
(such as glycosuria in non-
diabetics and low levels of
phosphate, magnesium or
|As needed||As needed||As needed||As needed|
1Also applies to first month after any dose modification.
Drag left on above table to view complete data.